Bioventus Reports First Quarter Financial Results
Bioventus Inc. reported financial results for the first quarter of 2026, showcasing a worldwide revenue increase of 7% to $132.1 million and a net income of $3.1 million. The growth is attributed to core business performance and effective operational execution. The company remains optimistic about achieving above-market growth while maintaining strong gross margins for reinvestment and profitability. Bioventus is also raising its full-year 2026 financial guidance based on improved cash flow and debt repayment.
DURHAM, N.C., May 06, 2026 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the three months ended March 28, 2026.